Instanyl® Non-Interventional Study

CompletedOBSERVATIONAL
Enrollment

309

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Breakthrough Cancer Pain
Trial Locations (65)

1478

Investigational site, Lørenskog

1603

Investigational site, Fredrikstad

2100

Investigational site, Copenhagen

3400

Investigational site, Hillerød

4068

Investigational site, Stavanger

4910

Investigational site, Kristiansand

5009

Investigational site, Bergen

5012

Investigational site, Bergen

5504

Investigational site, Haugesund

7400

Investigational site, Herning

8092

Investigational site, Bodø

8930

Investigational site, Randers

9038

Investigational site, Tromsø

11527

Investigational site, Athens

13616

Investigational site, Aix-en-Provence

14107

Investigational site, Lisieux

18547

Investigational site, Athens

25030

Investigational site, Besançon

25200

Investigational site, Montbéliard

29609

Investigational site, Brest

31059

Investigational site, Toulouse

33076

Investigational site, Bordeaux

38700

Investigational site, Grenoble

41000

Investigational site, Blois

44202

Investigational site, Nantes

44805

Investigational site, Saint-Herblain

45031

Investigational site, Orléans

54100

Investigational site, Nancy

54511

Investigational site, Vandœuvre-lès-Nancy

56324

Investigational site, Lorient

59236

Investigational site, Frelinghien

65000

Investigational site, Tarbes

67000

Investigational site, Strasbourg

67065

Investigational site, Strasbourg

68024

Investigational site, Colmar

68100

Investigational site, Mulhouse

69008

Investigational site, Lyon

69495

Investigational site, Pierre-Bénite

75010

Investigational site, Paris

75181

Investigational site, Paris

75970

Investigational site, Paris

80054

Investigational site, Amiens

89011

Investigational site, Auxerre

93009

Investigational site, Bobigny

95107

Investigational site, Argenteuil

95303

Investigational site, Pontoise

95602

Investigational site, Eaubonne

Unknown

Investigational site, Cork

Investigational site, Kilkenny

0310

Investigational site, Oslo

0407

Investigational site, Oslo

0514

Investigational site, Oslo

441 83

Investigational site, Alingsås

112 35

Investigational site, Stockholm

852 40

Investigational site, Sundsvall

187 77

Investigational site, Täby

751 85

Investigational site, Uppsala

593 81

Investigational site, Västervik

BT5 6NF

Investigational site, Belfast

ML6 6DJ

Investigational site, Lanarkshire

LU4 0DT

Investigational site, Luton

M20 4BX

Investigational site, Manchester

HA6 2RN

Investigational site, Middlesex

IP3 8LX

Investigational site, Suffolk

BA15 2LE

Investigational site, Wiltshire

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01045603 - Instanyl® Non-Interventional Study | Biotech Hunter | Biotech Hunter